Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Esperion Therapeutics
2639
Esperion Therapeutics
Health
Health and Wellness
Health Care
Medical
Technology
Biotechnology
Pharmaceuticals
Esperion Therapeutics discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.
Suggest edits
Founded
2008
Raised
$245.7M
Follow us
Companies in the same industry
Ritter Pharmaceuticals, Inc.
Provia Laboratories
Amplyx Pharmaceuticals, Inc
eXIthera Pharmaceuticals
Prexton Therapeutics SA
Labii Inc.
Pearl Therapeutics
molecular assemblies
Bioquark Inc.
Atlas Biomed
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$189,900,000
Post-IPO equity - 2015
$33,000,000
Venture capital - 2013
Team Size
10+
Employees
I work here
Location
United Kingdom
Headquarters
Explore United Kingdom
Pulse 2.0
Esperion Therapeutics (ESPR) Stock: Why It Increased Today
